[ Price : $8.95]
USC associate professor Genevieve Kanter says she is skeptical that the wholesale firing of HHS advisory committee experts to elim...[ Price : $8.95]
The National Association of Manufacturers calls on FDA to adhere to statutory and regulatory provisions governing expert panel mee...[ Price : $8.95]
An advocacy group takes aim at FDA, arguing in a new report that the agencys drug review process has grown more costly and restric...[ Price : $8.95]
Kodiak Sciences says its anti-VEGF therapy Zenkuda (tarcocimab tedromer) hit the mark in a second Phase 3 trial in diabetic retino...[ Price : $8.95]
Health experts breakdown a new FDA policy framework that could mark a turning point for highly individualized genetic medicines.[ Price : $8.95]
FDA warns Bethesda, MD-based Longhorn Vaccines and Diagnostics about Quality System, Medical Device Reporting, and Adulterated and...[ Price : $8.95]
FDA asks to look at Rezolutes Phase 3 data after the companys trial of ersodetug missed the primary endpoint, with the hope of cha...[ Price : $8.95]
Quoin Pharmaceuticals says FDA has signaled openness to a streamlined development path for its rare disease candidate QRX003, indi...